Latest FLAC reports update at 2022-11-09: 2022-Q3 ∙ 2022-Q2 ∙ 2022-Q1

Frazier Lifesciences Acquisition Corp. FLAC

$ 9.87 1.82%

Frazier Lifesciences Acquisition Corp. Balance Sheet 2011-2024 | FLAC

Annual Balance Sheet Frazier Lifesciences Acquisition Corp.

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	222 K	237 K	-	-	-	-	-	-	-	-	-
Total Liabilities	7.86 M	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-6.36 M	-	-	-	-	-	-	-	-	-	-
Total Assets	140 M	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	1.23 M	1.37 M	-	-	-	-	-	-	-	-	-
Book Value	132 M	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-6.36 M	-10.5 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Frazier Lifesciences Acquisition Corp.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	12.2 M	7.05 M	6.03 M	7.86 M	8.27 M	10.2 M	9.36 M	12.4 M	12.4 M	12.4 M	12.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-11.7 M	-6.18 M	-4.98 M	-6.36 M	-7.29 M	1.56 M	2.86 M	-10.5 M	-10.5 M	41.5 K	41.5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	139 M	139 M	139 M	140 M	139 M	139 M	140 M	140 M	140 M	140 M	140 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	376 K	615 K	788 K	1.23 M	636 K	789 K	1.16 M	1.37 M	1.37 M	1.37 M	1.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	127 M	132 M	133 M	132 M	131 M	129 M	130 M	127 M	127 M	127 M	127 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-11.7 M	-6.18 M	-4.97 M	-6.36 M	-7.29 M	-9.02 M	-7.72 M	-10.5 M	-10.5 M	5 M	5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency